TD Cowen Lowers Humana (NYSE:HUM) Price Target to $173.00

Humana (NYSE:HUM) had its target price reduced by equities researchers at TD Cowen from $260.00 to $173.00 in a report released on Friday,MarketScreener reports. The brokerage currently has a “hold” rating on the insurance provider’s stock. TD Cowen’s price objective points to a potential downside of 3.90% from the company’s previous close.

A number of other research firms have also recently weighed in on HUM. Wells Fargo & Company cut shares of Humana from an “overweight” rating to a “cautious” rating in a research note on Wednesday, January 7th. Barclays restated an “underperformer” rating on shares of Humana in a research report on Monday, January 5th. KeyCorp reiterated a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Robert W. Baird dropped their price objective on Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research note on Thursday, December 11th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $344.00 price objective on shares of Humana in a report on Tuesday, January 6th. Seven analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $242.04.

Humana Trading Up 0.7%

NYSE HUM opened at $180.02 on Friday. The company has a quick ratio of 2.02, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $21.65 billion, a P/E ratio of 18.47, a P/E/G ratio of 1.95 and a beta of 0.44. Humana has a 52-week low of $169.61 and a 52-week high of $315.35. The firm has a 50-day moving average price of $246.13 and a 200 day moving average price of $261.18.

Humana (NYSE:HUM) last released its earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The company had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. During the same quarter in the previous year, the firm posted ($2.16) EPS. The firm’s quarterly revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Equities research analysts expect that Humana will post 16.47 EPS for the current year.

Institutional Investors Weigh In On Humana

Hedge funds and other institutional investors have recently modified their holdings of the company. Sound View Wealth Advisors Group LLC lifted its stake in shares of Humana by 3.5% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock valued at $272,000 after buying an additional 36 shares during the period. Unison Advisors LLC lifted its stake in shares of Humana by 0.4% during the 3rd quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider’s stock worth $2,646,000 after purchasing an additional 37 shares during the period. CoreCap Advisors LLC grew its position in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the period. Insigneo Advisory Services LLC lifted its position in Humana by 3.0% during the third quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock worth $386,000 after buying an additional 43 shares during the period. Finally, Columbus Macro LLC boosted its stake in Humana by 5.5% in the 4th quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock worth $210,000 after buying an additional 43 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Humana

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Company outlook highlights aggressive Medicare Advantage membership expansion (management outlined ~25% MA membership growth for 2026), which supports longer‑term revenue scale and CenterWell unit growth. Humana outlines 25% Medicare Advantage membership growth for 2026
• Neutral Sentiment: Q4 results showed revenue growth (roughly +11–12% year‑over‑year) and CenterWell strength, while the company reported a larger GAAP loss; underlying revenue beats are supportive but offset by margin and investment headwinds. Humana Incurs Q4 Loss, Revenues Up Y/Y
• Negative Sentiment: Management warned of sharply lower 2026 earnings as lower Star Ratings and near‑term margin pressure weigh on profitability — the guidance disappointed investors and triggered much of the recent selloff. Humana projects sharply lower earnings as Medicare membership surges
• Negative Sentiment: Major firms have cut price targets and trimmed estimates after Q4 and the weak 2026 outlook — examples include Evercore ($260→$180), Cantor Fitzgerald ($290→$201), Leerink ($267→$185), Jefferies ($310→$235) and a TD Cowen Hold with a $173 target — pressuring sentiment and analyst consensus. Humana Analysts Slash Their Forecasts After Q4 Results TD Cowen Hold rating Evercore adjusts price target
• Negative Sentiment: Stock already hit a 52‑week low after the outlook — short‑term risk remains elevated as investors decide whether membership gains will offset Star Ratings and margin headwinds quickly enough. Humana Hits 52-Week Low After Weak Profit Outlook

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.